Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001437749-26-010879
Filing Date
2026-04-01
Accepted
2026-04-01 16:06:00
Documents
25
Period of Report
2026-05-20

Document Format Files

Seq Description Document Type Size
1 FORM DEF 14A dmtp20260331_def14a.htm   iXBRL DEF 14A 1091907
6 c2.jpg GRAPHIC 101480
7 chart.jpg GRAPHIC 91301
8 diamedicalogo.jpg GRAPHIC 6910
9 dmtp20260331_def14aimg002.jpg GRAPHIC 2051
10 kellensig.jpg GRAPHIC 6571
11 proxy1.jpg GRAPHIC 260035
12 proxy2.jpg GRAPHIC 341586
13 pvp.jpg GRAPHIC 81060
14 sig2.jpg GRAPHIC 5225
  Complete submission text file 0001437749-26-010879.txt   4095213

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA dmac-20251231.xsd EX-101.SCH 4764
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE dmac-20251231_def.xml EX-101.DEF 2076
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE dmac-20251231_lab.xml EX-101.LAB 2459
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE dmac-20251231_pre.xml EX-101.PRE 1574
28 EXTRACTED XBRL INSTANCE DOCUMENT dmtp20260331_def14a_htm.xml XML 89189
Mailing Address 301 CARLSON PARKWAY SUITE 210 MINNEAPOLIS MN 55305
Business Address 301 CARLSON PARKWAY SUITE 210 MINNEAPOLIS MN 55305 (763) 496-5454
DiaMedica Therapeutics Inc. (Filer) CIK: 0001401040 (see all company filings)

EIN.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36291 | Film No.: 26828147
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)